These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 30125546)
1. Antitumor activity of BJ-1207, a 6-amino-2,4,5-trimethylpyridin-3-ol derivative, in human lung cancer. Gautam J; Banskota S; Chaudhary P; Dahal S; Kim DG; Kang HE; Lee IH; Nam TG; Jeong BS; Kim JA Chem Biol Interact; 2018 Oct; 294():1-8. PubMed ID: 30125546 [TBL] [Abstract][Full Text] [Related]
2. BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway. Banskota S; Gautam J; Regmi SC; Gurung P; Park MH; Kim SJ; Nam TG; Jeong BS; Kim JA PLoS One; 2016; 11(1):e0148133. PubMed ID: 26824764 [TBL] [Abstract][Full Text] [Related]
3. Dual Inhibition of NOX2 and Receptor Tyrosine Kinase by BJ-1301 Enhances Anticancer Therapy Efficacy via Suppression of Autocrine-Stimulatory Factors in Lung Cancer. Gautam J; Ku JM; Regmi SC; Jeong H; Wang Y; Banskota S; Park MH; Nam TG; Jeong BS; Kim JA Mol Cancer Ther; 2017 Oct; 16(10):2144-2156. PubMed ID: 28536313 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and anticancer evaluation of 6-azacyclonol-2,4,6-trimethylpyridin-3-ol derivatives: M3 muscarinic acetylcholine receptor-mediated anticancer activity of a cyclohexyl derivative in androgen-refractory prostate cancer. Karmacharya U; Chaudhary P; Lim D; Dahal S; Awasthi BP; Park HD; Kim JA; Jeong BS Bioorg Chem; 2021 May; 110():104805. PubMed ID: 33725508 [TBL] [Abstract][Full Text] [Related]
5. Tryptophan hydroxylase 1 and 5-HT Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326 [TBL] [Abstract][Full Text] [Related]
6. Potent Inhibitory Effect of BJ-3105, a 6-Alkoxypyridin-3-ol Derivative, on Murine Colitis Is Mediated by Activating AMPK and Inhibiting NOX. Gurung P; Dahal S; Chaudhary P; Guragain D; Karmacharya U; Kim JA; Jeong BS Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365634 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model. Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols. Lee H; Banskota S; Kim DG; Been JH; Jin YJ; Gautam J; Jang H; Nam TG; Kim JA; Jeong BS Bioorg Med Chem Lett; 2014 Jul; 24(14):3131-6. PubMed ID: 24894557 [TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxy-7-azaindolin-2-one, a novel hybrid of pyridinol and sunitinib: design, synthesis and cytotoxicity against cancer cells. Shah S; Lee C; Choi H; Gautam J; Jang H; Kim GJ; Lee YJ; Chaudhary CL; Park SW; Nam TG; Kim JA; Jeong BS Org Biomol Chem; 2016 Jun; 14(21):4829-41. PubMed ID: 27145715 [TBL] [Abstract][Full Text] [Related]
10. 6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation. Chaudhary CL; Lim D; Chaudhary P; Guragain D; Awasthi BP; Park HD; Kim JA; Jeong BS J Enzyme Inhib Med Chem; 2022 Dec; 37(1):844-856. PubMed ID: 35296193 [TBL] [Abstract][Full Text] [Related]
11. Discovery of novel pyrrolo-pyridine/pyrimidine derivatives bearing pyridazinone moiety as c-Met kinase inhibitors. Wang LX; Liu X; Xu S; Tang Q; Duan Y; Xiao Z; Zhi J; Jiang L; Zheng P; Zhu W Eur J Med Chem; 2017 Dec; 141():538-551. PubMed ID: 29107421 [TBL] [Abstract][Full Text] [Related]
12. Novel imidazo[1,2-a]pyridine derivatives induce apoptosis and cell cycle arrest in non-small cell lung cancer by activating NADPH oxidase mediated oxidative stress. Bhavya K; Mantipally M; Roy S; Arora L; Badavath VN; Gangireddy M; Dasgupta S; Gundla R; Pal D Life Sci; 2022 Apr; 294():120334. PubMed ID: 35065161 [TBL] [Abstract][Full Text] [Related]
13. Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylation. Takeuchi A; Eto M; Shiota M; Tatsugami K; Yokomizo A; Kuroiwa K; Itsumi M; Naito S Int J Oncol; 2012 May; 40(5):1691-6. PubMed ID: 22344606 [TBL] [Abstract][Full Text] [Related]
14. The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse. Huang SM; Hsu PC; Chen MY; Li WS; More SV; Lu KT; Wang YC Int J Cancer; 2012 Aug; 131(3):722-32. PubMed ID: 22015944 [TBL] [Abstract][Full Text] [Related]
15. Erlotinib activates mitochondrial death pathways related to the production of reactive oxygen species in the human non-small cell lung cancer cell line A549. Qian X; Li J; Ding J; Wang Z; Zhang W; Hu G Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):487-94. PubMed ID: 19673930 [TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits the invasion of lung cancer cells by modulating the PKCα/Nox-2/ROS/ATF-2/MMP-9 signaling pathway. Fan Z; Duan X; Cai H; Wang L; Li M; Qu J; Li W; Wang Y; Wang J Oncol Rep; 2015 Aug; 34(2):691-8. PubMed ID: 26059056 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiproliferative activity of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety. Tang Q; Duan Y; Wang L; Wang M; Ouyang Y; Wang C; Mei H; Tang S; Xiong Y; Zheng P; Gong P; Zhu W Eur J Med Chem; 2018 Jan; 143():266-275. PubMed ID: 29197731 [TBL] [Abstract][Full Text] [Related]
18. PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis. Catena R; Luis-Ravelo D; Antón I; Zandueta C; Salazar-Colocho P; Larzábal L; Calvo A; Lecanda F Cancer Res; 2011 Jan; 71(1):164-74. PubMed ID: 21097719 [TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic activity of macrolactin A and its succinyl derivative is mediated through inhibition of class I PI3K activity and its signaling. Kang Y; Regmi SC; Kim MY; Banskota S; Gautam J; Kim DH; Kim JA Arch Pharm Res; 2015 Feb; 38(2):249-60. PubMed ID: 25547980 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway. Yeramian A; Sorolla A; Velasco A; Santacana M; Dolcet X; Valls J; Abal L; Moreno S; Egido R; Casanova JM; Puig S; Vilella R; Llombart-Cussac A; Matias-Guiu X; Martí RM Int J Cancer; 2012 Feb; 130(4):967-78. PubMed ID: 21445974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]